x

Like our Facebook Page

   
Early Times Newspaper Jammu, Leading Newspaper Jammu
 
Breaking News :   Back Issues  
 
news details
Taking of hormones increase risk of breast cancer
4/20/2007 11:12:00 PM
=========================


BL KAK NEW DELHI, Apr 20
Hormone replacement therapy (HRT) is not risk-free. Studies done in the United States and United Kingdom showed women who take hormones after menopause--hormone replacement therapy--will have a mugh higher risk of breast cancer and a slightly higher risk of ovarian cancer.
From 2001 to 2004, breast cancer rates fell almost 9 percent in U.S. -- a dramatic decline, researchers reported in New England Journal of Medicine.
Government statistics showed breast cancer rate plunged in 2003 as millions of women stopped taking hormones after a major study tied hormones use to higher heart, stroke and breast cancer risks. And in 2004 the rate leveled off. The numbers suggested the drop was due to not using the drug, not a fluke.
A study in the Lancet medical journal found women who used HRT were 20 percent more likely to die from ovarian cancer than those who did not use HRT in Britain. Dr. Valerie Beral and colleagues at the Cancer Research UK Epidemiology Unit in Oxford said their findings suggested that 1,000 extra women in Britain had died from ovarian cancer between 1991 and 2005 because they were using hormone replacement therapy.
They used data from the "Million Women Study", which looked at just under a million women, about half of whom were current of former HRT users. "The effect of HRT on ovarian cancer should not be viewed in isolation, especially since use of HRT also affects the risk of breast and endometrial cancer", they wrote.
"The total incidence of these three cancers in the study population is 63 percent higher in current users of HRT than never users", they were quoted as saying. They added: "Thus when ovarian, endometrial and breast cancer are taken together, use of HRT results in a material increase in these common cancers".
But they stressed that young women who need the drug to relieve serious symptoms of menopause should still consider taking it because new, lower-dose formulations are available and doctors know to prescribe it for shorter periods of time.
==================================
  Share This News with Your Friends on Social Network  
  Comment on this Story  
 
 
top stories of the day
 
 
 
Early Times Android App
STOCK UPDATE
 
 
 
 
 
 
 
   
Home About Us Top Stories Local News National News Sports News Opinion Editorial ET Cetra Advertise with Us ET E-paper
 
 
J&K RELATED WEBSITES
J&K Govt. Official website
Jammu Kashmir Tourism
JKTDC
Mata Vaishnodevi Shrine Board
Shri Amarnath Ji Shrine Board
Shri Shiv Khori Shrine Board
UTILITY
Train Enquiry
IRCTC
Matavaishnodevi
BSNL
Jammu Kashmir Bank
State Bank of India
PUBLIC INTEREST
Passport Department
Income Tax Department
JK CAMPA
JK GAD
IT Education
Web Site Design Services
EDUCATION
Jammu University
Jammu University Results
JKBOSE
Kashmir University
IGNOU Jammu Center
SMVDU